Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022857

CHAIRMAN & CEO gave up 11,144 shares (to pay taxes)

  • CHAIRMAN & CEO acquired 23,043 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Option exercise +16,474 84,126 D
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Shares withheld for taxes −7,967 $26.74 $213,038 76,159 D
Patel Sanj K CHAIRMAN & CEO 2024-09-02 Option exercise +6,569 82,728 D
Patel Sanj K CHAIRMAN & CEO 2024-09-02 Shares withheld for taxes −3,177 $26.74 $84,953 79,551 D
Derivatives
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Grant or award · Restricted Share Unit +24,950 24,950 D
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Grant or award · Share Option +129,750 129,750 D
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Option exercise · Restricted Share Unit −9,992 19,983 D
Patel Sanj K CHAIRMAN & CEO 2024-09-01 Option exercise · Restricted Share Unit −6,482 19,443 D
Patel Sanj K CHAIRMAN & CEO 2024-09-02 Option exercise · Restricted Share Unit −6,569 6,569 D
Loading xslF345X05/form4-09052024_120917.xml…